AJLA UZICANIN: Open Payments
NPI 1083447031 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,880 in 138 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $846 · 2025 $4,880
Food & beverage: $4,762Education: $115Travel & lodging: $3
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 24 | $1,429 |
| ABBVIE INC. | 37 | $1,296 |
| Janssen Biotech, Inc. | 15 | $460 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $423 |
| Lilly USA, LLC | 7 | $231 |
| Celltrion USA Inc. | 5 | $181 |
| Phathom Pharmaceuticals, Inc. | 5 | $170 |
| GENZYME CORPORATION | 3 | $168 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $148 |
| Biocon Biologics Inc | 3 | $65 |
Products named: REZDIFFRA, SKYRIZI, TREMFYA, RINVOQ, ENTYVIO, OMVOH, VOQUEZNA, DUPIXENT.
Industry payments across TX — which companies pay providers there.
